Peter Krammer

This inventor holds 13 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 5 EPO patents. Top assignees: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts, Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts, Universitaetsklinikum Heidelberg. Active years: 1999-2026.

USPTO Granted Patents = 13 (Patent Applications = 10)

% Patents Active = 61.5

CIPO Patents = 5

EPO Patents = 5 (Patent Applications = 14)

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 10(Granted Patents)

Company Filing History:

8 out of 166

Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts

patents

2 out of 20

Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts

patents

2 out of 4

Universitaetsklinikum Heidelberg

Deutsches Krebsforschungszentrum

patents

6. 1 out of 1

Dkfz Deutchers Krebsforschungszentrum

patent

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12704512 - Modulators of the function of the core domain of annexins, and uses thereof in autoimmune and/or cancer therapy (2026-08-11),

2. 12329800 - Annexin-coated particles (2025-06-17),

3. 11851463 - Core domain of annexins and uses thereof in antigen delivery and vaccination (2023-12-26),

4. 10947283 - Core domain of annexins and uses thereof in antigen delivery and vaccination (2021-03-16),

5. 9850308 - Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo (2017-12-26),

6. 9387192 - Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer (2016-07-12),

7. 9309320 - Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo (2016-04-12),

8. 8563500 - Methods and compounds for treating diseases caused by reactive oxygen species (2013-10-22),

9. 7935339 - Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries (2011-05-03),

10. 6770474 - p53 binding areas (2004-08-03),

11. 6696547 - Mutant DEDD proteins for regulating apoptosis (2004-02-24),

12. 6485929 - Method for inhibiting CD95-independent apoptosis in AIDS (2002-11-26),

13. 5891434 - Monoclonal antibodies to the APO-1 antigen (1999-04-06),

Title: Peter Krammer - Innovative Inventor from Heidelberg

Introduction: Peter Krammer is a renowned inventor hailing from Heidelberg, Germany, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Peter Krammer holds several patents in the areas of renewable energy, medical devices, and artificial intelligence, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Peter Krammer has worked with leading research institutions and companies, consistently pushing the boundaries of technological advancement.

Collaborations: Throughout his career, Peter Krammer has collaborated with top universities and multinational corporations, fostering a culture of innovation and knowledge exchange.

Conclusion: Peter Krammer's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor in Heidelberg and beyond.